The results show that resveratrol and rapamycin have marked effects not only on the mTOR signaling activity and metabolic marker expression but also on the composition of gut microbiota, suggesting that specific microbial groups correlate with the pathophysiological phenotypes associated with obesity and T2D. This evidence concerns the gene MTOR and type 2 diabetes mellitus.